Navigation path

eu calender
What's in it for me?
Europe in the UK
The commissioners
EP in the UK
London researchers spearhead new EU diabetes drive
E-mail this pageE-mail this pagePrintPrint

Top London-based scientists are to lead major new EU-funded projects to improve understanding of diabetes and better treat the estimated 350 million sufferers worldwide, including about 3 million in the UK. The projects were launched at a major diabetes conference in Brussels.

    London researchers spearhead new EU diabetes drive

    The UK led projects are two of a EUR 16m (£13.4m) set of four linked studies bringing together European and global  experts and focusing on how people's genetic make-up, surroundings and lifestyle influence their chances of getting diabetes and affect how the disease progresses. Three-quarters of the finance comes from the EU.

    By concentrating on different populations from South Asia, the Mediterranean region, or sub-Saharan Africa and comparing people living in their country of origin with those from the same background who have moved to other parts of the world, the projects aim to improve our knowledge of the root causes of diabetes and ultimately to develop new diagnostic tools, treatments, exercise programmes and diets.

    The EU Commissioner for Research, Innovation and Science, Máire Geoghegan-Quinn said: "Diabetes is set to rise sharply, with devastating consequences for our health and Europe's healthcare systems. To break this trend, we need to invest in research to better understand, prevent and treat this debilitating disease. These research projects will lead the way".

    Prof Graham Hitman from Queen Mary, University of London will coordinate research worth EUR 3.9m (£3.3m), by experts from eight countries, on the prevalence and incidence of diabetes in a number of South Asian populations, with a focus on signs that can predict the disease already in early life.

    Prof. Hitman said: “We are currently witnessing an epidemic of diabetes in East London with our local South Asian population who have 3-6 times the prevalence of diabetes compared to average figures in England; furthermore, the disease presents 10-15 years earlier. This mirrors what is happening in the South Asian sub-continent where 1 in 4 of all people over the age of 20 years either has diabetes or pre-diabetes. This exciting study of great local and international importance will target South Asian pregnant women to combine prevention strategies, state-of-the-art genomics, social sciences and public health strategies as an opportunity to prevent the early signs of diabetes in the offspring. It is truly a privilege to lead this international consortium and work so closely with colleagues in Bangladesh, Pakistan and India on problems that affect us all.”

    Several more UK institutions are involved, including the London School of Hygiene and Tropical Medicine, University College London, the University of East London, the University of Southampton and the University of Exeter.

    Dr John Chambers of Imperial College will lead a team from nine countries - also including Oxford and Cambridge Universities and UK company Cellcentric Ltd - in a EUR 3.9m (£3.3m) project evaluating the risk factors involved in the particularly high rates of type 2 diabetes in South Asian populations.

    The other two projects, led by French and Dutch scientists, will analyse the genetic and environmental factors of insulin resistance in immigrant Mediterranean populations and type 2 diabetes and obesity in Ghanaian populations in Ghana and Europe. The London School of Hygiene and Tropical Medicine is also a partner in the latter project.


    The new project cluster joins the EU's current portfolio of more than 100 research projects on diabetes and obesity, with EU funding of over €270m (£225m).

    Diabetes is nothing short of an epidemic. In the EU, 32 million people suffer from the disease, with about a further 6 million unaware that they are living with it. This figure is set to rise by 25 per cent to about 40 million by 2030. World-wide, around 350 million people have diabetes according to the World Health Organisation, and more than 900 million are expected to be diagnosed with, or as having high risk of developing, type 2 diabetes within the next two decades.

    In Europe, type 2 diabetes is likely to reduce life expectancy by up to 10 years. The disease contributes to coronary heart disease, stroke, peripheral vascular disease and end-stage renal disease, making it the fifth leading cause of death worldwide. It is even worse for type 1 suffers whose life-span can be cut by over 20 years.

    The costs linked to diabetes are spiralling upwards and are estimated to account for 8 to up to 18 per cent of total healthcare costs in European countries. 

    More information
    EU research projects on diabetes and obesity

    EU research website on health, diabetes and obesity

    Conference "Diabesity ­ a world-wide challenge"

    EC London press office: 020 7973 1971

    Dr. John Chambers, Imperial College of Science, Technology and Medicine:

    Prof. Graham Hitman, Blizard Institute of Cell and MolecularScience:

    Tel: +44 (0)20 7377 7111


    Please note: all amounts expressed in sterling are for information purposes only.


    Last update: 13/02/2012  |Top